Aberrant expression of cyclin E in low-risk node negative breast cancer

Acta Oncologica

Volumn 47, Issue 8, 2008, Pages 1539-1545

  Ahlin, Cecilia ^a,b   Gruhne, Bettina ^c   Holmqvist, Marit ^d   Zetterberg, Anders ^c   Fjällskog, Marie Louise ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Regional Cancer Centre Uppsala Orebro   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN E; RECEPTOR;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; MICROSCOPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RELAPSE; STAINING; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CASE-CONTROL STUDIES; CYCLIN A; CYCLIN E; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; HUMANS; NEOPLASM STAGING; ONCOGENE PROTEINS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 54349127172     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860701856581     Document Type: Article

References (23)

1. Churman B, Roberts J. Cell cycle and cancer. J Natl Cancer Inst 1995;87:1499-501.
2. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-7.
3. Koff A, Giordano A, Desia D, Yamashita K, Harper JW, Elledge SJ, et al. Formation and activation of a cyclin E-cdk2 complex during G1 phase of the human cell cycle. Science 1992;257:1689-94.
4. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S transition. Mol Cell Biol 1995;15:2612-24.
5. Ohtsubo M, Roberts JM. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 1993;259:1908-12.
6. Spruck CH, Won KA, Rees SI. Deregulated cyclin E induces chromosomal instability. Nature 1999;401:297-300.
7. Keyomarsi K, Pardee AB. Redundant Cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 1993;90:1112-6.
8. Buckley MF, Sweeney KJE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993;8:2127-33.
9. Nielsen NH, Arnerlöv C, Emdin SO, Landberg G. Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status. Br J Cancer 1996;74:874-80.
10. Schraml P, Bucher C, Bissig H, Nocito A, Haas P, Wilber K, et al. Cyclin E overexpression and amplification in human tumors. J Pathol 2003;3:375-82.
11. Gray-Bablin J, Zalvide J, Fox MP, Knickerbocker CJ, DeCaprio JA, Keyomarsi K. Cyclin E, a redundant cyclin in breast cancer. Proc Natl Acad Sci USA 1996;93:15215-20.
12. Porter D, Zang N, Danes C, McGahren M, Harwell R, Faruki S, Keyomarsi K. Tumor-specific proteolytic processing of cyclin E generates lower-molecular- weight forms. Mol Cell Biol 2001;21:6254-69.
13. Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfeldt O, Reed SI. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 2001;413:316-22.
14. Sieuwerts A, Look M, Meijer-van Gelder M, Timmermans M, Trapman A, Rodriguez Garcia R, et al. Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node negative breast cancer patients. Clin Cancer Res 2006;12:3319-28.
15. Keyomarsi K, Tucker SL, Buchholtz TA, Callister M, Ding Y, Hotobagyi G, et al. Cyclin E and survival in patients with breast cancer. New Engl J Med 2002;347:1566-75.
16. Scott KA, Walker RA. Lack of immunoreactivity in non-malignant breast and association with proliferation in breast cancer. Br J Cancer 1997;76:1288-92.
17. Kühling H, Alm P, Olsson H, Fernö M, Baldetorp B, Parwesch R, et al. Expression of cyclins E, A and B, and prognosis in lymph node-negative breast cancer. J Pathol 2003;199:424-31.
18. Lindahl T, Landberg G, Ahlgren J, Nordgren H, Norberg T, Klaar S, et al. Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer. Carcinogenesis 2004;25:375-80.
19. Wang L, Shao Z-M. Cyclin E expression and prognosis in breast cancer patients: A meta-analysis of published studies. Cancer Invest 2006;24:581-7.
20. Erlandsson F, Wählby C, Ekholm-Reed S, Hellström A-C, Bengtsson E, Zetterberg A. Abnormal expression pattern of cyclin E in tumour cells. Int J Cancer 2003;104:369-75.
21. Erlandsson F, Linnman C, Ekholm S, Bengtsson E, Zetterberg A. A detailed analysis of cyclin A accumulation et the G1/S border in normal and transformed cells. Exp Cell Res 2000;259:86-95.
22. Erlandsson F, Martinsson-Ahlzén H-S, Wallin K-L, Hellström A-C, Andersson S, Zetterberg A. Parallel cyclin E and cyclin A expression in neoplastic lesions of the uterine cervix. Br J Cancer 2006;94:1045-50.
23. Bukholm I, Bukholm G, Nesland J. Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas. Int J Cancer 2001;93:283-7.